Medication info
Neostar Tablet 40/5 mg

Neostar Tablet 40/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Shinil Pharmaceutical Co., Ltd.
Appearance
White and light blue biconvex oval double tablet
Packaging
30 tablets (10 tablets/PTP*3)
Approval status
Active

MFDS item code 201804441 · Approved 2018.11.08 · Insurance code 653805360

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amount of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, for patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years and over, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
Pediatric patients 18 years of age or younger: Use of this medicine is not recommended because its safety and efficacy have not been established.

Ingredients

Manufacturer
Shinil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication assists in effectively controlling blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with telmisartan or amlodipine alone. Such treatment plays an important role in reducing the risk of complications from hypertension and maintaining health. This drug is used to dilate blood vessels and reduce the burden on the heart to lower blood pressure stably.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amount of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, for patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years and over, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

Pediatric patients 18 years of age or younger: Use of this medicine is not recommended because its safety and efficacy have not been established.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can pose serious risks to the fetus. If pregnancy is confirmed, the use of this medication should be discontinued as soon as possible. It should not be taken if there is an allergy to the active ingredient or similar components. Women who are pregnant or may become pregnant, as well as nursing women, should not use this drug. It should not be taken by patients with severe hepatic impairment or obstructive biliary disease. Patients with severe heart-related diseases, especially those with left ventricular outflow obstruction or severe hypotension, and those with cardiac shock also should avoid this drug. In diabetic patients with significantly reduced kidney function, the combination of this medication with certain other drugs is prohibited. Patients with primary aldosteronism or specific heart valve diseases, and those with liver dysfunction, should use this medication carefully. Patients with gastrointestinal diseases should also use it with caution; special attention is needed for patients with renal artery hypertension, renal failure, and the elderly. This drug commonly causes side effects like dizziness and peripheral edema, and serious side effects have been reported rarely. If blood pressure drops too low, one should lie down immediately and rest, and seek appropriate medical treatment if necessary. Due to the risk of increased potassium levels in the blood, electrolyte levels should be checked regularly when combining with related medications. Caution is needed when driving or operating dangerous machinery, as this drug may cause drowsiness or dizziness. There may be interactions with other medications, so it is essential to inform healthcare providers of any medications being taken. In the case of overdose, symptoms like decreased blood pressure, dizziness, and heart problems may occur, requiring immediate emergency treatment. The safety and efficacy in children have not been sufficiently established, thus its use is not recommended for this population.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 98 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • sensory disturbances
  • sensory loss
  • taste disorder
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gum hypertrophy
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • hepatic dysfunction
  • liver disorder
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • frequent urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • weakness
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a light-tight, closed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

White and light blue biconvex oval double tablet

Package unit

30 tablets (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.